Literature DB >> 1489208

Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.

M Picard1, F Malouin.   

Abstract

Cefaclor sustained its inhibitory activity against a beta-lactamase-producing strain of Haemophilus influenzae. Although a relatively high permeability coefficient was calculated for ampicillin compared with that calculated for cefaclor, the resulting periplasmic concentration of cefaclor was 5.7 times that of ampicillin. The efficacy of cefaclor may be due to its higher beta-lactamase resistance, which allows it to achieve a greater periplasmic concentration and adequate binding to crucial penicillin-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489208      PMCID: PMC284379          DOI: 10.1128/AAC.36.11.2569

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.

Authors:  L D Tremblay; J L'Ecuyer; P Provencher; M G Bergeron
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

2.  American Academy of Pediatrics Committee on Infectious Diseases: Treatment of bacterial meningitis.

Authors: 
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

3.  Biological characterization of a new radioactive labeling reagent for bacterial penicillin-binding proteins.

Authors:  D A Preston; C Y Wu; L C Blaszczak; D E Seitz; N G Halligan
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

5.  Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b.

Authors:  V Vachon; D J Lyew; J W Coulton
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

6.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

7.  In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.

Authors:  G V Doern; R Vautour; D Parker; T Tubert; B Torres
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

Authors:  T R Parr; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae.

Authors:  D A Serfass; P M Mendelman; D O Chaffin; C A Needham
Journal:  J Gen Microbiol       Date:  1986-10

10.  Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities.

Authors:  F Malouin; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more
  3 in total

1.  Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin.

Authors:  Frank S Kaczmarek; Thomas D Gootz; Fadia Dib-Hajj; Wenchi Shang; Shawn Hallowell; Melissa Cronan
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Use of biotinylated beta-lactams and chemiluminescence for study and purification of penicillin-binding proteins in bacteria.

Authors:  M Dargis; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

3.  Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.

Authors:  Abdelhamid Asli; Eric Brouillette; Kevin M Krause; Wright W Nichols; François Malouin
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.